The protective role of telmisartan against nephrotoxicity induced by x-ray contrast media in rat model

Acta Radiologica

Volumn 50, Issue 7, 2009, Pages 754-759

  Duan, Shao Bin ^a   Wang, Yu Hui ^a   Liu, Fu You ^a   Xu, Xiang Qing ^a   Wang, Pian ^a   Zou, Qin ^a   Peng, You Ming ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Contrast media; Contrast induced nephropathy; Telmisartan

Indexed keywords

ANGIOTENSIN II; APOPTOSIS; APOPTOTIC; BIOCHEMICAL ANALYZERS; CASPASE-3; CONTRAST-INDUCED NEPHROPATHY; CONTROL GROUPS; DEOXYURIDINE; DIATRIZOATE; END-LABELING; FLUOROMETRIC METHOD; INTERVENTIONAL PROCEDURES; IOHEXOL; MALE RATS; NEPHROPATHY; NEPHROTOXICITY; RAT KIDNEYS; RAT MODEL; RENAL INJURY; RENAL TISSUE; SPRAGUE-DAWLEY RATS; TELMISARTAN; TUBULAR CELLS; X RAY CONTRAST MEDIA;

ANIMALS; BODY FLUIDS; CELL DEATH; CELL MEMBRANES; GLYCEROL; RATS;

CONTRAST MEDIA;

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; CASPASE 3; CONTRAST MEDIUM; CREATININE; DIATRIZOATE; IOHEXOL; TELMISARTAN;

ANALYSIS OF VARIANCE; ANIMAL; APOPTOSIS; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; KIDNEY DISEASE; METABOLISM; NICK END LABELING; OSMOLARITY; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; APOPTOSIS; BENZIMIDAZOLES; BENZOATES; CASPASE 3; CONTRAST MEDIA; CREATININE; DIATRIZOATE; IN SITU NICK-END LABELING; IOHEXOL; KIDNEY DISEASES; OSMOLAR CONCENTRATION; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 69949124716     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850902995544     Document Type: Article

References (28)

1. Fishman EK, Reddan D. What are radiologists doing to prevent contrast-induced nephropathy compared with measures supported by current evidence? A survey of European radiologists on RCIN associated with computed tomography. Acta Radiol 2008;49:310-20.
2. Goldenberg I, Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ 2005;172:1461-71.
3. Thomsen HS, Morcos SK, Barrett BJ. Contrast-induced nephropathy: the wheel has turned 360 degrees. Acta Radiol 2008;49:646-57.
4. Aspelin P, Aubry P, Fransson SG, Strasser R, Will-enbrock R, Lundkvist J. Cost-effectiveness of iodixanol in patients at high risk of contrast induced nephropathy. Am Heart J 2005;149:298-303. (Pubitemid 40348539)
5. Aspelin P, Aubry P, Fransson SG, Strasser R, Will-enbrock R, Berg KJ. Nephrotoxicity in high-risk patients study of iso-osmolar and low osmolar non-ionic contrast media study investigators: nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003;348:491-9.
6. Katzberg RW. Contrast media-induced nephrotoxicity: which pathway? Radiology 2005;235:752-5.
7. Maeder M, Klein M, Fehr T, Rickli H. Contrast nephropathy: review focusing on prevention. J Am Coll Cardiol 2004;44:1763-71.
8. Duan SB, Liu FY, Luo JA, Wu HW, Liu RH, Peng YM, et al. Nephrotoxicity of high- and low-osmolar contrast media. The protective role of amlodipine in a rat model. Acta Radiol 2000;41:503-7.
9. Briguori C, Airoldi F, Morici N, Colombo A. New pharmacological protocols to prevent or reduce contrast media nephropathy. Minerva Cardioangiol 2005;53: 49-58.
10. Russo D, Minutolo R, Cianciaruso B, Memoli B, Conte G, De Nicola L. Early effect of contrast media on renal hemodynamics tubular function in chronic renal failure. J Am Soc Nephrol 1995;6:1451-8.
11. Yang D, Jia RH, Yang DP, Ding GH, Huang CX. Dietary hypercholesterolemia aggravates contrast media-induced nephropathy. Chin Med J 2004;117: 542-6.
12. Gupta RK, Kapoor A, Tewari S, Sinha N, Sharma RK. Captopril for prevention of contrast-induced nephro-pathy in diabetic patients: a randomised study. Indian Heart J 1999;51:521-6.
13. Rosenstock JL, Bruno R, Kim JK, Lubarsky L, Schaller R, Panagopoulos G, et al. The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy. Int Urol Nephrol 2008;40:749-55.
14. Shoda J, Kanno Y, Suzuki H. A five-year comparison of the renal protective effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with non-diabetic nephropathy. Intern Med 2006;45:193-8.
15. Battershill AJ, Scott LJ. Telmisartan: a review of its use in the management of hypertension. Drugs 2006;66: 51-83.
16. Duan SB, Zhou XR, Liu FY, Peng YM, Chen YY, Pei YY, et al. Comparative cytotoxicity of high-osmolar and low-osmolar contrast media on HKC in vitro. J Nephrol 2006;19:717-24.
17. Dlamini A, Mbita Z, Zungu M. Genealogy, expression, and molecular mechanisms in apoptosis. Pharmacol Ther 2004;101:1-15.
18. Haller C, Hizoh I. The cytotoxicity of iodinated radio-contrast agents on renal cells in vitro. Invest Radiol 2004;39:149-54.
19. Schick CS, Haller C. Comparative cytotoxicity of ionic and nonionic radiocontrast agents on MDCK cell monolayers in vitro. Nephrol Dial Transplant 1999;14: 342-7.
20. Peer A, Averbukh Z, Berman S, Modai D, Averbukh M, Weissgarten J. Contrast media augmented apoptosis of cultured renal mesangial, tubular, epithelial, and hepatic cell. Invest Radiol 2003;38:177-82.
21. Cunha MA, Schor N. Effects of gentamicin, lipopoly-saccharide, and contrast media on immortalized proximal tubular cells. Ren Fail 2002;24:687-90.
22. Kaushal GP, Kaushal V, Hong X, Shah SV. Role and regulation of activation of caspases in cisplatin induced injury to renal tubular epithelial cell. Kidney Int 2001; 60:1726-36.
23. Wong VY, Keller PM, Nuttall ME, Kikly K, DeWolf WE Jr, Lee D, et al. Role of caspases in human renal proximal tubular epithelial cell apoptosis. Eur J Pharmacol 2001;433:135-40.
24. Soejima K, Uozumi J, Kanou T, Fujiyama C, Masaki Z. Nonionic contrast media are less nephrotoxic than ionic contrast media to rat renal cortical slics. Toxicol Lett 2003;143:17-25.
25. From AM, Bartholmai BJ, Williams AW, McDonald FS. Iodixanol compared to iohexol for contrast procedures: a case-matched retrospective cohort study. Acta Radiol 2008;49:409-14.
26. Heyman SN, Rosen S, Rosenberger C. Renal parench-ymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy. Clin J Am Soc Nephrol 2008;3:288-96.
27. Cibulskyte D, Pedersen M, Horlyck A, Marcussen N, Hansen HE, Frøkiær J. Telmisartan attenuates chronic cyclosporin A nephrotoxicity in a pig model. Nephrol Dial Transplant 2007;22:369-75.
28. Ruilope LM, Redon J, Schmieder R. Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from The ONTARGET Trial Programme. Vasc Health Risk Manag 2007;3:1-9.